The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding method
Vanni Bucci,
Doyle V. Ward,
Shakti Bhattarai,
Mayra Rojas-Correa,
Ayan Purkayastha,
Devon Holler,
Ming Da Qu,
William G. Mitchell,
Jason Yang,
Samuel Fountain,
Abigail Zeamer,
Catherine S. Forconi,
Gavin Fujimori,
Boaz Odwar,
Caitlin Cawley,
Ann M. Moormann,
Mireya Wessolossky,
Ana Maldonado-Contreras
Affiliations
Vanni Bucci
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Doyle V. Ward
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Shakti Bhattarai
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Mayra Rojas-Correa
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Ayan Purkayastha
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Devon Holler
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Ming Da Qu
Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
William G. Mitchell
Department of Internal Medicine/Pediatrics, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Jason Yang
Department of Medicine - Internal Medicine, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Samuel Fountain
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Abigail Zeamer
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Catherine S. Forconi
Department of Medicine - Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Gavin Fujimori
Department of Medicine - Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Boaz Odwar
Department of Medicine - Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Caitlin Cawley
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Ann M. Moormann
Department of Medicine - Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Mireya Wessolossky
Department of Medicine - Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
Ana Maldonado-Contreras
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA
ABSTRACT SARS-CoV-2-positive patients exhibit gut and oral microbiome dysbiosis, which is associated with various aspects of COVID-19 disease (1–4). Here, we aim to identify gut and oral microbiome markers that predict COVID-19 severity in hospitalized patients, specifically severely ill patients compared to moderately ill ones. Moreover, we investigate whether hospital feeding (solid versus enteral), an important cofounder, influences the microbial composition of hospitalized COVID-19 patients. We used random forest classification machine learning models with interpretable secondary analyses. The gut, but not the oral microbiota, was a robust predictor of both COVID-19-related fatality and severity of hospitalized patients, with a higher predictive value than most clinical variables. In addition, perturbations of the gut microbiota due to enteral feeding did not associate with species that were predictive of COVID-19 severity. IMPORTANCE SARS-CoV-2 infection leads to wide-ranging, systemic symptoms with sometimes unpredictable morbidity and mortality. It is increasingly clear that the human microbiome plays an important role in how individuals respond to viral infections. Our study adds to important literature about the associations of gut microbiota and severe COVID-19 illness during the early phase of the pandemic before the availability of vaccines. Increased understanding of the interplay between microbiota and SARS-CoV-2 may lead to innovations in diagnostics, therapies, and clinical predictions.